Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

October 20, 2020 | Daily News

FDA has brought in seven temporary voting members to fill out its 17-member vaccines advisory committee, which will meet this Thursday (Oct. 22) to discuss general COVID-19 vaccine development and licensure or emergency use authorization data standards and policy issues.

October 20, 2020 | Daily News

The head of the industry-led Antimicrobial (AMR) Action Fund said the group is on track to begin investing in companies that manufacture promising new antibiotics by the first quarter of fiscal 2021, despite the COVID-19 pandemic.

October 19, 2020 | Daily News

The Supreme Court’s recent decision to punt back to a lower court a case over FDA’s in-person prescribing requirements for the abortion pill mifepristone has women’s health advocates, who oppose the requirements, on guard.

October 19, 2020 | Daily News

As FDA continues to urge the courts to reinstate its in-person prescribing restrictions on mifepristone, one women’s health expert is using the opening to proceed with her plans to study the prescribing and dispensing of mifepristone through telehealth without the need for ultrasounds or physical exams.

October 19, 2020 | Daily News

In three separate efforts, two consumer groups filed suits to try to force the government to hand over coronavirus-related contracts with drug makers and another group of government-oversight nonprofits filed Freedom of Information Act requests demanding access to contracts funneled through the private government contract management firm Advanced Technology International.

October 19, 2020 | Daily News

A lobbying group called Infusion Providers Alliance has formed to oppose international reference pricing for drugs, specialty pharmacy mandates and a measure in the Senate Finance Committee’s drug pricing bill that would lower reimbursement at physician practices that generate a significant part of their revenue from administering drugs.

October 16, 2020 | Daily News

If the demonstration that caps monthly insulin costs works, CMS might run similar demos for other drugs, Center for Medicare and Medicaid Innovation Center Director Brad Smith said Friday (Oct. 16).

October 16, 2020 | Daily News

Support for the Affordable Care Act ticked up by 6% since last month and voters now trust Democratic presidential candidate Joe Biden more than President Donald Trump on every health care issue, including to lower drug costs, which had been the only topic where voters trusted the president over his rival in the September, according the Kaiser Family Foundation’s health tracking poll released Friday (Oct. 16).

October 16, 2020 | Daily News

Pfizer will apply for emergency use authorization for its COVID-19 vaccine around the third week of November, assuming it gets a positive data readout on efficacy and safety by then, company CEO Albert Bourla says in a Friday (Oct. 16) open letter.

October 15, 2020 | Daily News

Eli Lilly is still pursuing emergency use authorization for its COVID-19 antibody therapy, LY-CoV555 (bamlanivimab), for use in mild-to-moderate COVID-19 patients, even as its National Institutes of Health-sponsored trial of hospitalized patients remains on hold while an independent group of experts reviews the trial data, a company spokesperson confirmed to Inside Health Policy.

October 15, 2020 | Daily News

Despite the president’s boasts, a top Trump campaign policy adviser said legal and regulatory challenges might thwart the administration’s drug import rule.

October 15, 2020 | Daily News

Joe Biden said he would like to adopt a variation of the German drug pricing model, which makes drug companies justify prices to an independent panel, according to a press pool account of comments the Democratic presidential candidate made Thursday (Oct 14).

October 15, 2020 | Daily News

An official with the Biotechnology Innovation Organization said he’s disappointed that the federal government failed to discuss pull incentives for antimicrobial medicines in its recently released national plan to reduce antibiotic resistance.

October 13, 2020 | Daily News

The Democratic leaders of congressional health care committees asked the Government Accountability Office to quickly review the legality of the president’s plan to send $200 Medicare drug discount cards to seniors before the election.

October 13, 2020 | Daily News

Johnson & Johnson’s decision to temporarily pause its COVID-19 vaccine phase 3 clinical trial because of an “unexplained illness” in a trial participant does not affect the company’s manufacturing processes and plans, a J&J official told investors on Tuesday (Oct. 13).

October 13, 2020 | Daily News

In an effort to respect the sovereignty of tribal nations, the federal government will allow tribes to choose whether they receive future COVID-19 vaccines through their states or through the Indian Health Service, Jay Butler, deputy director for infectious diseases at the Centers for Disease Control and Prevention, said on a Friday (Oct. 9) press call.

October 13, 2020 | Daily News

Ryan White clinics have sued the Health Resources and Services Administration for not acting against drug makers that cut off 340B discounts for drugs provided through contract pharmacies, coming as the agency also faces growing pressure from lawmakers and other 340B providers to take action.

October 13, 2020 | Daily News

Ryan White clinics have sued the Health Resources and Services Administration for not acting against drug makers that cut off 340B discounts for drugs provided through contract pharmacies, coming as the agency also faces growing pressure from lawmakers and other 340B providers to take action.

October 09, 2020 | Daily News

House Energy & Commerce ranking Republican Greg Walden (OR) and Senate health committee Chair Lamar Alexander (R-TN) on Friday (Oct. 9) asked stakeholders for suggestions on how to reform the 340B drug discount program, taking aim in part at contract pharmacies as some drug makers look to limit the discounts providers can access through those entities.

October 09, 2020 | Daily News

An Operation Warp Speed official on Friday (Oct. 9) said the federal government is on track to have a hundred million or more doses of COVID-19 vaccine manufactured by year-end -- enough to vaccinate the most vulnerable Americans -- and that there could be upwards of 700 million total doses available by March or April 2021.

Pages